Skip to content

Efficacy and safety of electroacupuncture combined with external application of traditional Chinese medicine in the treatment of Bell 's palsy: a randomized controlled study

Efficacy and safety of electroacupuncture combined with external application of traditional Chinese medicine in the treatment of Bell 's palsy: a randomized controlled study

Status
Unknown
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230405002
Enrollment
164
Registered
2023-04-05
Start date
2023-04-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This study aims to evaluate the clinical efficacy of electroacupuncture combined with external application of traditional Chinese medicine (EATCM) in the treatment of Bell &#039

Interventions

180 patients with BP who met the inclusion and exclusion criteria were randomly divided into treatment group 1, treatment group 2 and control group according to the ratio of 1:1:1. Treatment group 1 w
Experimental Other
electroacupuncture combined with external application of traditional Chinese medicine

Sponsors

Hongmei Ma
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Months to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients with diagnosis of idiopathic facial neuritis (Bell 's palsy), and the diagnostic criteria referring to the Chinese Guidelines for the diagnosis and treatment of idiopathic facial paralysis (2) Patients aged be equal or greater than 18 years and less than or equal to 70 years (3) First attack, unilateral facial paralysis (4) Onset time within 1 month, the grading of House-Brackmann scale be equal or greater than grade 3 (5) Patients voluntarily joined this study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: (1)Central facial paralysis, or facial paralysis caused by Lyme disease, encephalitis, tumor and other reasons; (2)Patients with severe mental illness or unconsciousness that could not cooperate with the treatment; (3)There were wounds and scars at the treatment site affecting the treatment; (4)Allergic to the study drug; (5) Patients participated in or were participating in other experimental studies in the past 1 month.

Design outcomes

Primary

MeasureTime frame
Sunnybrook Facial Grading System (SFGS) 3 weeks On a scale of 0 to 100

Secondary

MeasureTime frame
House-Brackmann Grading Scale (HBGS) 3 weeks HBGS was classified into six grades

Countries

China

Contacts

Public ContactLiang Guo

Linfen People Hospital

gl4519hawk@163.com18635736676

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026